137 related articles for article (PubMed ID: 18462868)
1. The inhibitory effect of p75 neurotrophin receptor on growth of human hepatocellular carcinoma cells.
Yuanlong H; Haifeng J; Xiaoyin Z; Jialin S; Jie L; Li Y; Huahong X; Jiugang S; Yanglin P; Kaichun W; Jie D; Daiming F
Cancer Lett; 2008 Sep; 268(1):110-9. PubMed ID: 18462868
[TBL] [Abstract][Full Text] [Related]
2. The biological role of the low-affinity p75 neurotrophin receptor in esophageal squamous cell carcinoma.
Okumura T; Tsunoda S; Mori Y; Ito T; Kikuchi K; Wang TC; Yasumoto S; Shimada Y
Clin Cancer Res; 2006 Sep; 12(17):5096-103. PubMed ID: 16951226
[TBL] [Abstract][Full Text] [Related]
3. p75NTR enhances PC12 cell tumor growth by a non-receptor mechanism involving downregulation of cyclin D2.
Fritz MD; Mirnics ZK; Nylander KD; Schor NF
Exp Cell Res; 2006 Oct; 312(17):3287-97. PubMed ID: 16887120
[TBL] [Abstract][Full Text] [Related]
4. p75 neurotrophin receptor suppresses the proliferation of human gastric cancer cells.
Jin H; Pan Y; Zhao L; Zhai H; Li X; Sun L; He L; Chen Y; Hong L; Du Y; Fan D
Neoplasia; 2007 Jun; 9(6):471-8. PubMed ID: 17603629
[TBL] [Abstract][Full Text] [Related]
5. p75 neurotrophin receptor inhibits invasion and metastasis of gastric cancer.
Jin H; Pan Y; He L; Zhai H; Li X; Zhao L; Sun L; Liu J; Hong L; Song J; Xie H; Gao J; Han S; Li Y; Fan D
Mol Cancer Res; 2007 May; 5(5):423-33. PubMed ID: 17510309
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line.
Mazzanti R; Platini F; Bottini C; Fantappiè O; Solazzo M; Tessitore L
Biochem Pharmacol; 2009 Jul; 78(1):21-32. PubMed ID: 19447220
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition and gene induction in human hepatocellular carcinoma cell exposed to sodium 4-phenylbutanoate.
Wang CT; Meng M; Zhang JC; Jin CJ; Jiang JJ; Ren HS; Jiang JM; Qin CY; Yu DQ
Chin Med J (Engl); 2008 Sep; 121(17):1707-11. PubMed ID: 19024104
[TBL] [Abstract][Full Text] [Related]
8. Expression and p75 neurotrophin receptor dependence of cholesterol synthetic enzymes in adult mouse brain.
Korade Z; Mi Z; Portugal C; Schor NF
Neurobiol Aging; 2007 Oct; 28(10):1522-31. PubMed ID: 16887237
[TBL] [Abstract][Full Text] [Related]
9. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
10. Identification of ROBO1 as a novel hepatocellular carcinoma antigen and a potential therapeutic and diagnostic target.
Ito H; Funahashi S; Yamauchi N; Shibahara J; Midorikawa Y; Kawai S; Kinoshita Y; Watanabe A; Hippo Y; Ohtomo T; Iwanari H; Nakajima A; Makuuchi M; Fukayama M; Hirata Y; Hamakubo T; Kodama T; Tsuchiya M; Aburatani H
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3257-64. PubMed ID: 16740745
[TBL] [Abstract][Full Text] [Related]
11. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.
Narla G; Kremer-Tal S; Matsumoto N; Zhao X; Yao S; Kelley K; Tarocchi M; Friedman SL
Oncogene; 2007 Jun; 26(30):4428-34. PubMed ID: 17297474
[TBL] [Abstract][Full Text] [Related]
12. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells.
Huang S; Zhang F; Miao L; Zhang H; Fan Z; Wang X; Ji G
Oncol Rep; 2008 Nov; 20(5):1053-9. PubMed ID: 18949401
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor carcinoembryonic antigen-related cell adhesion molecule 1 potentates the anchorage-independent growth of human hepatoma HepG2 cells.
Hokari M; Matsuda Y; Wakai T; Shirai Y; Sato M; Tsuchiya A; Takamura M; Yamagiwa S; Suzuki K; Ohkoshi S; Ichida T; Kawachi H; Aoyagi Y
Life Sci; 2007 Jul; 81(4):336-45. PubMed ID: 17612570
[TBL] [Abstract][Full Text] [Related]
14. Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycle.
Tang H; Tang XY; Liu M; Li X
Clin Chim Acta; 2008 Aug; 394(1-2):81-8. PubMed ID: 18485897
[TBL] [Abstract][Full Text] [Related]
15. Synemin down-regulation in human hepatocellular carcinoma does not destabilize cytoskeletons in vivo.
Liu YH; Cheng CC; Lai YS; Chao WT; Pei RJ; Hsu YH; Ho CC
Biochem Biophys Res Commun; 2011 Jan; 404(1):488-93. PubMed ID: 21144834
[TBL] [Abstract][Full Text] [Related]
16. The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-alpha.
Oie S; Ono M; Yano H; Maruyama Y; Terada T; Yamada Y; Ueno T; Kojiro M; Hirano K; Kuwano M
Int J Oncol; 2006 Dec; 29(6):1469-78. PubMed ID: 17088986
[TBL] [Abstract][Full Text] [Related]
17. Negatively regulating mechanism of Sirpalpha1 in hepatocellular carcinoma: an experimental study.
Qin JM; Yan HX; Liu SQ; Wan XW; Zeng JZ; Cao HF; Qiu XH; Wu MC; Wang HY
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):246-51. PubMed ID: 16698585
[TBL] [Abstract][Full Text] [Related]
18. Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels.
Baiz D; Pozzato G; Dapas B; Farra R; Scaggiante B; Grassi M; Uxa L; Giansante C; Zennaro C; Guarnieri G; Grassi G
Biochimie; 2009 Mar; 91(3):373-82. PubMed ID: 19041685
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of TANGO in colon and hepatocellular carcinomas.
Arndt S; Bosserhoff AK
Oncol Rep; 2007 Oct; 18(4):885-91. PubMed ID: 17786351
[TBL] [Abstract][Full Text] [Related]
20. E2F8 contributes to human hepatocellular carcinoma via regulating cell proliferation.
Deng Q; Wang Q; Zong WY; Zheng DL; Wen YX; Wang KS; Teng XM; Zhang X; Huang J; Han ZG
Cancer Res; 2010 Jan; 70(2):782-91. PubMed ID: 20068156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]